ABL Bio
@ablbio.com
It is based on developing bispecific antibody cancer programs.
ABL Bio's Company Logos
ABL Bio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#F78908
Tahiti Gold
247, 137, 8
32, 94, 50
0, 45, 97, 3
#FFDB29
Sunglow
255, 219, 41
50, 100, 58
0, 14, 84, 0
#965A3A
Potters Clay
150, 90, 58
21, 44, 41
0, 40, 61, 41
About ABL Bio
ABL Bio is a leading biotech research company that specializes in developing drugs for immune oncology and degenerative brain diseases. Our core values are focused on improving lives, collaboration, innovation, and breakthrough therapies. We aspire to become a globally competitive pharmaceutical company by building innovative platforms and pipelines.
With a diverse range of platform technologies, ABL Bio possesses the capability to treat challenging diseases. We have achieved significant milestones, including approval for ABL103 clinical trial phase 1 in Korea, patent registration in Japan for ABL503, and a successful half-year revenue of 49 billion KRW. We are constantly searching for talented individuals to join our team and contribute to our mission of offering better treatment options for debilitating diseases.
Visit our website to learn more about our pipeline of therapies for degenerative brain diseases, immune oncology, and antibody-drug conjugates
Company type
Public Company
Year founded
2016
Company size
51-200 employees
